Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.334, 2001-01, pp. : 5-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Bisoprolol cost-effective addition in CHF in Sweden
Inpharma, Vol. 1, Iss. 1309, 2001-01 ,pp. :
Access to resources
Recommend
Carvedilol "highly cost-effective" for CHF in Japan
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 447, 2004-01 ,pp. :
Ramipril `highly cost-effective' in Sweden
Inpharma, Vol. 1, Iss. 1342, 2002-01 ,pp. :
Most cost-effective therapies for urinary incontinence in Sweden . . .
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 644, 2012-01 ,pp. :
Boceprevir a cost-effective addition in HCV therapy
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 671, 2013-01 ,pp. :